Novel diagnostic tools for identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy: patient-level, single-group, diagnostic trial
Open Access
- 8 March 2022
- journal article
- research article
- Published by Springer Nature in Alzheimer's Research & Therapy
- Vol. 14 (1) , 1-10
Abstract
Introduction: Basic studies suggest that olfactory dysfunction and functional near-infrared spectroscopy (fNIRS) can be used as tools for the diagnosis of mild cognitive impairment (MCI); however, real-world evidence is lacking. We investigated the potential diagnostic efficacy of olfactory-stimulated fNIRS for early detection of MCI and/or Alzheimer disease (AD). Methods: We conducted a patient-level, single-group, diagnostic interventional trial involving elderly volunteers (age >60 years) suspected of declining cognitive function. Patients received open-label olfactory-stimulated fNIRS for measurement of oxygenation difference in the orbitofrontal cortex. All participants underwent amyloid PET, MRI, Mini-Mental State Examination (MMSE), and Seoul Neuropsychological Screening Battery (SNSB). Results: Of 97 subjects, 28 (28.9%) were cognitively normal, 32 (33.0%) had preclinical AD, 21 (21.6%) had MCI, and 16 (16.5%) had AD. Olfactory-stimulated oxygenation differences in the orbitofrontal cortex were associated with cognitive impairment; the association was more pronounced with cognitive severity. Olfactory-stimulated oxygenation difference was associated with MMSE (adjusted β [aβ] 1.001; 95% CI 0.540−1.463), SNSB language and related function (aβ, 1.218; 95% CI, 0.020−2.417), SNSB memory (aβ, 1.963; 95% CI, 0.841−3.084), SNSB frontal/executive function (aβ, 1.715; 95% CI, 0.401−3.029) scores, standard uptake value ratio from amyloid PET (aβ, −10.083; 95% CI, −19.063 to −1.103), and hippocampal volume from MRI (aβ, 0.002; 95% CI, 0.001−0.004). Olfactory-stimulated oxygenation difference in the orbitofrontal cortex was superior in diagnosing MCI and AD (AUC, 0.909; 95% CI, 0.848−0.971), compared to amyloid PET (AUC, 0.793; 95% CI, 0.694−0.893) or MRI (AUC, 0.758; 95% CI, 0.644−0.871). Discussion: Our trial showed that olfactory-stimulated oxygenation differences in the orbitofrontal cortex detected by fNIRS were associated with cognitive impairment and cognitive-related objectives. This novel approach may be a potential diagnostic tool for patients with MCI and/or AD. Trial registration: CRIS number, KCT0006197.Keywords
Funding Information
- Ministry of Health and Welfare (MD-PhD/Medical Scientist Training Program)
- National Research Foundation of Korea (NRF-2016M3C7A1905475)
- Institute for Information and Communications Technology Promotion (MSIT; No.2020-0-01969)
- Ministry of Science and ICT of Korea (21-BR-03-05)
- National Research Foundation of Korea (NRF-2014M3C7A1046041)
This publication has 41 references indexed in Scilit:
- Brain activation during dual-task walking and executive function among older adults with mild cognitive impairment: a fNIRS studyAging Clinical and Experimental Research, 2013
- Tissue oxygen saturation and pulsatility index as markers for amnestic mild cognitive impairment: NIRS and TCD studyClinical Neurophysiology, 2013
- Reduced Frontal Activation during a Working Memory Task in Mild Cognitive Impairment: a Non‐Invasive Near‐Infrared Spectroscopy StudyCNS Neuroscience & Therapeutics, 2012
- Use of Florbetapir-PET for Imaging β-Amyloid PathologyJAMA, 2011
- Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia PatientsJournal of Korean Medical Science, 2010
- Quantification of Five Neuropsychological Approaches to Defining Mild Cognitive ImpairmentThe American Journal of Geriatric Psychiatry, 2009
- The relationship between cerebral Alzheimer's disease pathology and odour identification in old ageJournal of Neurology, Neurosurgery & Psychiatry, 2007
- A quantitative near-infrared spectroscopy study: A decrease in cerebral hemoglobin oxygenation in Alzheimer’s disease and mild cognitive impairmentBrain and Cognition, 2006
- Olfactory bulb changes in Alzheimer's diseaseActa Neuropathologica, 1987
- Report of the committee on methods of clinical examination in electroencephalographyElectroencephalography and Clinical Neurophysiology, 1958